GPER G-1 Development Group receives STTR Grant for the Development of an Innovative Diabetes Therapeutic Targeting GPER

GPER-1 Development Group LLC has licensed the promising technology from the University of New Mexico and New Mexico State University  PRESS RELEASE: JULY 15, 2020Albuquerque, NM – GPER G-1 Development Group, a portfolio company of the New Mexico Start-Up Factory, is developing a novel therapeutic for the treatment of diabetes and obesity.  The company’s leading drug candidate for the […]